Found: 9

Select item for more details and to access through your institution.

  • MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 448, p. 1, doi. 10.1126/scitranslmed.aan4470
    By:
    • Yohe, Marielle E.;
    • Gryder, Berkley E.;
    • Shern, Jack F.;
    • Song, Young K.;
    • Chou, Hsien-Chao;
    • Sindiri, Sivasish;
    • Mendoza, Arnulfo;
    • Patidar, Rajesh;
    • Zhang, Xiaohu;
    • Guha, Rajarashi;
    • Butcher, Donna;
    • Isanogle, Kristine A.;
    • Robinson, Christina M.;
    • Luo, Xiaoling;
    • Chen, Jin-Qiu;
    • Walton, Ashley;
    • Awasthi, Parirokh;
    • Edmondson, Elijah F.;
    • Difilippantonio, Simone;
    • Wei, Jun S.
    Publication type:
    Article

  • Clonality and Evolutionary History of Rhabdomyosarcoma.

    Published in:
    PLoS Genetics, 2015, v. 11, n. 3, p. 1, doi. 10.1371/journal.pgen.1005075
    By:
    • Chen, Li;
    • Shern, Jack F.;
    • Wei, Jun S.;
    • Yohe, Marielle E.;
    • Song, Young K.;
    • Hurd, Laura;
    • Liao, Hongling;
    • Catchpoole, Daniel;
    • Skapek, Stephen X.;
    • Barr, Frederic G.;
    • Hawkins, Douglas S.;
    • Khan, Javed
    Publication type:
    Article

  • Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression.

    Published in:
    Nature Structural & Molecular Biology, 2007, v. 14, n. 9, p. 814, doi. 10.1038/nsmb1290
    By:
    • Mitin, Natalia;
    • Betts, Laurie;
    • Yohe, Marielle E.;
    • Der, Channing J.;
    • Sondek, John;
    • Rossman, Kent L.
    Publication type:
    Article

  • New prospectives on treatment opportunities in RASopathies.

    Published in:
    American Journal of Medical Genetics. Part C: Seminars in Medical Genetics, 2022, v. 190, n. 4, p. 541, doi. 10.1002/ajmg.c.32024
    By:
    • Gelb, Bruce D.;
    • Yohe, Marielle E.;
    • Wolf, Cordula;
    • Andelfinger, Gregor
    Publication type:
    Article

  • Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20386-8
    By:
    • Pomella, Silvia;
    • Sreenivas, Prethish;
    • Gryder, Berkley E.;
    • Wang, Long;
    • Milewski, David;
    • Cassandri, Matteo;
    • Baxi, Kunal;
    • Hensch, Nicole R.;
    • Carcarino, Elena;
    • Song, Young;
    • Chou, Hsien-Chao;
    • Yohe, Marielle E.;
    • Stanton, Benjamin Z.;
    • Amadio, Bruno;
    • Caruana, Ignazio;
    • De Stefanis, Cristiano;
    • De Vito, Rita;
    • Locatelli, Franco;
    • Chen, Yidong;
    • Chen, Eleanor Y.
    Publication type:
    Article

  • Insights into pediatric rhabdomyosarcoma research: Challenges and goals.

    Published in:
    2019
    By:
    • Yohe, Marielle E.;
    • Heske, Christine M.;
    • Stewart, Elizabeth;
    • Adamson, Peter C.;
    • Ahmed, Nabil;
    • Antonescu, Cristina R.;
    • Chen, Eleanor;
    • Collins, Natalie;
    • Ehrlich, Alan;
    • Galindo, Rene L.;
    • Gryder, Berkley E.;
    • Hahn, Heidi;
    • Hammond, Sharon;
    • Hatley, Mark E.;
    • Hawkins, Douglas S.;
    • Hayes, Madeline N.;
    • Hayes‐Jordan, Andrea;
    • Helman, Lee J.;
    • Hettmer, Simone;
    • Ignatius, Myron S.
    Publication type:
    journal article

  • CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14684-4
    By:
    • Liu, Zhihui;
    • Zhang, Xiyuan;
    • Lei, Haiyan;
    • Lam, Norris;
    • Carter, Sakereh;
    • Yockey, Oliver;
    • Xu, Max;
    • Mendoza, Arnulfo;
    • Hernandez, Edjay R.;
    • Wei, Jun S.;
    • Khan, Javed;
    • Yohe, Marielle E.;
    • Shern, Jack F.;
    • Thiele, Carol J.
    Publication type:
    Article

  • Chemical genomics reveals histone deacetylases are required for core regulatory transcription.

    Published in:
    Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11046-7
    By:
    • Gryder, Berkley E.;
    • Wu, Lei;
    • Woldemichael, Girma M.;
    • Pomella, Silvia;
    • Quinn, Taylor R.;
    • Park, Paul M. C.;
    • Cleveland, Abigail;
    • Stanton, Benjamin Z.;
    • Song, Young;
    • Rota, Rossella;
    • Wiest, Olaf;
    • Yohe, Marielle E.;
    • Shern, Jack F.;
    • Qi, Jun;
    • Khan, Javed
    Publication type:
    Article

  • Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1–Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.

    Published in:
    JAMA Dermatology, 2023, v. 159, n. 10, p. 1112, doi. 10.1001/jamadermatol.2023.2621
    By:
    • Sargen, Michael R.;
    • Kim, Jung;
    • Potjer, Thomas P.;
    • Velthuizen, Mary E.;
    • Martir-Negron, Arelis E.;
    • Odia, Yazmin;
    • Helgadottir, Hildur;
    • Hatton, Jessica N.;
    • Haley, Jeremy S.;
    • Thone, Gretchen;
    • Widemann, Brigitte C.;
    • Gross, Andrea M.;
    • Yohe, Marielle E.;
    • Kaplan, Rosandra N.;
    • Shern, Jack F.;
    • Sundby, R. Taylor;
    • Astiazaran-Symonds, Esteban;
    • Yang, Xiaohong R.;
    • Carey, David J.;
    • Tucker, Margaret A.
    Publication type:
    Article